Clinical studies revealed that the expression of STING was significantly reduced in HCC tissues compared to the controls, and lower expression of STING was associated with a more advanced tumor stages and a worse survival (27) as well with poor prognosis for patients with gastric cancer (28). Here, STING1 is linked to gastric cancer.